NDAQ:KAVL - Post Discussion
Post by
AveragePenny on Mar 17, 2022 12:31pm
Kaival Brands Reports Fiscal 2022 First Quarter Financial
Corporate Updates Subsequent to the Fiscal First Quarter 2022
- Judicial Stay of Bidi Vapor's Marketing Denial Order ("MDO") was granted on February 1, 2022. The court-ordered stay means that the MDO, which covered the non-tobacco flavored BIDI® Sticks, is not legally in force. Accordingly, Kaival Brands anticipates being able to continue marketing and selling all eleven BIDI® Stick products, subject to the U.S. Food and Drug Administration's ("FDA") enforcement discretion, while Bidi Vapor continues with its merits case challenging the legality of the MDO. FDA has indicated that it is prioritizing enforcement against companies that have either not submitted PMTAs, or whose PMTAs have been refused acceptance or filing by FDA, or whose PMTAs remain subject to MDOs.
- The Company regained compliance with Nasdaq's minimum bid price listing requirement pursuant to Nasdaq Listing Rule 5550(a)(2) on February 18, 2022.
- The Company continues to pursue international distribution and expects to provide an update in the second quarter of 2022.
[url=https://www.prnewswire.com/news-releases/kaival-brands-reports-fiscal-2022-first-quarter-financial-results-864694489.htmlhttps://www.prnewswire.com/news-releases/kaival-brands-reports-fiscal-2022-first-quarter-financial-results-864694489.html]https://www.prnewswire.com/news-releases/kaival-brands-reports-fiscal-2022-first-quarter-financial-results-864694489.html[/url]
Be the first to comment on this post